FIELD: medicine.
SUBSTANCE: group of inventions discloses a dry composition for treating, preventing or limiting TNF-α signalling consisting of a sugar source and inositol, wherein the sugar source is selected from the group consisting of fructose and galactose, the sugar source is present in an amount of 70% and the inositol is present in an amount of 30%. The use of the dry composition and a method for preparing the composition are also disclosed.
EFFECT: prevention or limitation of TNF-α signalling and associated pro-inflammatory cytokines in the individual.
9 cl, 5 ex
